Evidence map›Paper›PMID 31895924›Full record

ArticlePloS one2020

Genetic predisposition to celiac disease in Kazakhstan: Potential impact on the clinical practice in Central Asia.

Dimitri Poddighe, Aida Turganbekova, Dana Baymukasheva, Zhazira Saduakas, Zhuldyz Zhanzakova, Saniya Abdrakhmanova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Celiac Disease Revisited.GE Portuguese journal of gastroenterology · 2022
    Review
  10. Article
  11. Celiac disease in children: A review of the literature.World journal of clinical pediatrics · 2021
    Review
  12. Current research status of HLA in immune-related diseases.Immunity, inflammation and disease · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dimitri PoddigheDepartment of Medicine, Nazarbayev University School of Medicine, Nur-Sultan City, Kazakhstan.ORCID 0000-0001-6431-9334
Aida TurganbekovaRSE on REM «Research and Production Center of Transfusion», Ministry of Health of the Republic of Kazakhstan, Nur-Sultan City, Kazakhstan.
Dana BaymukashevaRSE on REM «Research and Production Center of Transfusion», Ministry of Health of the Republic of Kazakhstan, Nur-Sultan City, Kazakhstan.
Zhazira SaduakasRSE on REM «Research and Production Center of Transfusion», Ministry of Health of the Republic of Kazakhstan, Nur-Sultan City, Kazakhstan.
Zhuldyz ZhanzakovaRSE on REM «Research and Production Center of Transfusion», Ministry of Health of the Republic of Kazakhstan, Nur-Sultan City, Kazakhstan.
Saniya AbdrakhmanovaRSE on REM «Research and Production Center of Transfusion», Ministry of Health of the Republic of Kazakhstan, Nur-Sultan City, Kazakhstan.
Ministry of Health of the Republic of Kazakhstan · KZNazarbayev University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCeliac disease (CD) is a systemic immune-mediated disorder developing in HLA genetically predisposed individuals carrying HLA-DQ2 and/or HLA-DQ8 molecules. Recent evidences supported a predominant importance of HLA-DQB1 locus and, in particular, HLA-DQB1*02 alleles. This diagnosis is poorly considered in Kazakhstan, because of the assumption that CD is not prevalent in this population.

objectiveTo demonstrate that the genetic predisposition to CD in Kazakhstan is not negligible and is actually comparable to Western populations.

methodsThrough the analysis of HLA-DQ genotypes of healthy bone marrow donors from Kazakhstan's national registry, we estimated the HLA-related genetic predisposition to CD in the country.

resultsWe demonstrated that the frequency of CD-related HLA-DQB1 alleles and, as a consequence, of predisposed individuals to CD in Kazakhstan is significant and comparable to countries with the highest disease prevalence.

conclusionConsidering the dietary style in Kazakhstan, including wheat as a staple food, these results provided a preliminary background of knowledge to expect a significant CD prevalence in Kazakhstan and Central Asia by implementing appropriate and cost-effective diagnostic strategies.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticAdolescentAdultAllelesCase-Control StudiesCeliac DiseaseFemaleGenotypeHLA-DQ beta-ChainsHumansKazakhstanMaleMiddle AgedPractice Patterns, Physicians'PrevalenceHLA-DQB1 antigenHLA-DQ beta-Chains

Identifiers

PMID31895924
PMCPMC6939901
OpenAlexW2998680911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.